Related by context. All words. (Click for frequent words.) 70 Application MAA 67 Application BLA 66 Marketing Authorization Application MAA 66 Marketing Authorisation Application 66 Lambert Eaton Myasthenic 65 Syndrome LEMS 65 Marketing Authorisation Application MAA 65 Peginterferon alfa 2b 65 nasal calcitonin product 64 Raptiva R 64 methylnaltrexone bromide 64 mesylate tablets 63 liver resection surgeries 63 Marketing Authorization Application 63 INSPIRE Trial Phase III 63 FDA approvable letter 63 SWX BSLN 63 oropharyngeal candidiasis OPC 63 Dementia Related Psychosis 63 Wafer polifeprosan 63 ZEGERID Chewable Tablets 62 cSSTI 62 BCG refractory carcinoma 62 humanized interleukin 6 62 R bendamustine hydrochloride 62 RANK Ligand inhibitor 62 orphan designation 62 myelodysplastic myeloproliferative diseases 62 GTC recombinant form 62 Orphan Drug status 61 phase III isavuconazole 61 Initiates Enrollment 61 exocrine pancreatic insufficiency EPI 61 FDA Approvable Letter 61 Vitrasert R 61 Firdapse ™ amifampridine phosphate 61 Marketing Authorisation 61 highly purified pasteurized 61 submitted Marketing Authorization 61 vapreotide acetate 61 rasagiline tablets 61 DIFICID ™ 61 Romiplostim 61 Orphan Drug designation 61 memantine HCl 61 CIMZIA r 61 Cellegesic 61 Zenvia ™ 61 submitted Biologics License 60 Oracea TM 60 OMP designation 60 agalsidase alfa 60 FDA APPROVES 60 Pirfenidone 60 Initiates Phase III 60 Orphan Medicinal Product 60 REBETOL combination therapy 60 Kit CD# positive 60 iloprost Inhalation Solution 60 Orphan Status 60 cutaneous T 60 Revolade 60 ketolide antibiotic 60 Granted Orphan Drug 60 GABITRIL 60 Initiates Phase II 60 buccal tablets 60 severe hypercholesterolemia 60 Rhucin R 60 FACTIVE R gemifloxacin 60 Firdapse TM amifampridine phosphate 60 Pivotal Phase III 60 Marketing Authorization Applications 60 Kuvan R 60 Fast Track Status 60 interferon gamma 1b 60 Esbriet ® 60 DORIBAX 60 balsalazide disodium Capsules 60 Neulasta R 60 PNP inhibitor 60 hoFH 60 Positive Opinion 60 acyclovir Lauriad R 60 Meets Primary Endpoint 60 sapropterin dihydrochloride 60 Mylan Receives Approval 59 oropharyngeal candidiasis 59 sitaxsentan sodium 59 Nexavar sorafenib 59 rheumatoid arthritis psoriatic arthritis 59 miconazole MBT 59 CONBRIZA 59 Announces Tentative Approval 59 known teratogen substance 59 Tibotec Therapeutics division 59 orphan medicinal product 59 Fast Track designations 59 arthritis PsA 59 Complicated Skin 59 FOLOTYN ® 59 FDA Accepts 59 Actemra tocilizumab 59 dasatinib Sprycel ® 59 STELARA TM 59 SinuNase ™ 59 Serostim ® 59 COLAZAL R 59 Evoltra TM 59 hypereosinophilic syndrome 59 ALLSCHWIL BASEL SWITZERLAND 59 Loramyc ™ 59 HYVISC R 59 Soliris TM eculizumab 59 toenail onychomycosis 59 non constipation irritable 59 Friedreich Ataxia FRDA 59 subcutaneous formulation 59 refractory chronic lymphocytic 59 Receives Orphan Drug Designation 59 Marketing Authorization 59 Raptiva ® 59 lexidronam injection 59 NasdaqGM NTEC today 59 esophageal candidiasis 59 JOULFERON 58 PRN FDA Approves 58 R rilonacept Injection 58 Submits Biologics License Application 58 Loramyc 58 Thalidomide Pharmion 58 SABER ™ 58 application sNDA 58 Eloxatin ® 58 Acute Attacks 58 Pegloticase 58 Soriatane 58 Zorbtive TM 58 sorafenib tablets 58 ocular itching associated 58 APF# NDA 58 synthetic lipoglycopeptide antibiotic 58 Market Authorization Application 58 relapsing remitting MS RRMS 58 Basilea Toctino R 58 Completes Patient Enrollment 58 acetonide FA 58 testosterone gel LibiGel 58 lintuzumab SGN 58 Submits NDA 58 Zevtera ™ 58 induced macular edema 58 levocetirizine 58 fentanyl buccal tablet 58 MAGE A3 ASCI 58 unresectable recurrent 58 Lilly Cymbalta 58 PEGylated anti 58 Receives Orphan Drug 58 Ranolazine 58 GTC recombinant human 58 acute HAE 58 Orphan Drug Status 58 Belimumab 58 Febuxostat 58 sNDA 58 Initiate Phase 58 Sanvar R 58 Arzerra ofatumumab 58 ILUVIEN ® 58 diarrhea predominant irritable 58 Keppra ® XR 58 Angiox ® 58 herpetic keratitis 58 CAMPATH R 58 Nasdaq OSCI 58 Personalized Immunotherapy 58 Lubiprostone 58 markets HP Acthar 58 ZALBIN 58 refractory acute promyelocytic 58 Liprotamase 58 R Saizen R 58 Orphan Drug designations 58 diabetic neuropathic pain 58 initiated Phase Ib 58 Trobalt 58 octreotide acetate 58 non splenectomized 57 Kristalose ® lactulose 57 FDA Complete Response 57 mitoxantrone plus 57 vinorelbine emulsion 57 metastatic dermatofibrosarcoma protuberans DFSP 57 Drug Submission 57 refractory cutaneous T 57 Actelion Ltd 57 Opterone R 57 Submits Response 57 Sanctura XR 57 thetreatment 57 superficial basal cell carcinoma 57 Preotact R 57 REBETOL combination 57 Tasigna nilotinib 57 nanofiltered plasma derived 57 Solesta TM 57 supplemental Biologics License Application 57 Lenocta TM 57 Receives Fast Track 57 supplemental biologics 57 HepaGam B TM 57 Kamada AAT 57 TEMODAL 57 Vitrasert ® 57 ADP receptor antagonist 57 diarrhea fatigue asthenia 57 GATTEX TM 57 XIAFLEX TM 57 Zenpep 57 Biologics License Application BLA 57 KRYSTEXXA TM pegloticase 57 assigned PDUFA 57 Aryplase 57 Submits Supplemental 57 Neupro R 57 SNT MC# 57 oral methylnaltrexone 57 exocrine pancreatic insufficiency 57 LSE SHP.L 57 Somatuline 57 Orphan Drug Designation 57 Firazyr 57 lymphoma CTCL 57 Cutaneous T 57 Biologic License Application BLA 57 Evoltra ® 57 Gel repository corticotropin injection 57 lucinactant 57 Complete Response letter 57 Adenuric R 57 advanced metastatic HER2 57 investigational antiplatelet agent 57 5 lipoxygenase inhibitor 57 MOVIPREP R 57 Auxilium Pharma 57 alfa 2a 57 ALVESCO R 57 treat opioid induced 57 Nivestim 57 Torisel 57 Aviptadil 57 PEGINTRON TM 57 opioid induced constipation OIC 57 Gliadel R 57 terlipressin 57 Oral Calcitonin 57 SUPPRELIN R LA 57 Cimzia certolizumab pegol 57 adalimumab Humira 57 rheumatoid arthritis RA psoriatic 57 SPRYCEL ® 57 Romidepsin 57 Inhalation Aerosol 57 post operative ileus 57 PDUFA Date 57 SIX BSLN 57 Amgen Neulasta R 57 Oracea ® 57 Phase III Clinical Trial 57 Keppra ® levetiracetam 57 Velac 57 Deferiprone 57 Brilique 56 itraconazole Sporanox 56 Premarket Approval Application 56 Diabetic Macular Edema 56 REPLAGAL 56 testosterone buccal system 56 Complete Response 56 glucocorticoid induced osteoporosis 56 Safinamide 56 pediatric Crohn disease 56 anti inflammatory NSAID 56 Increlex TM 56 Aloprim TM allopurinol sodium 56 ALN HPN 56 Ophthalmic Drugs Advisory 56 prokinetic agent 56 Orphan designation 56 Severe VOD 56 recurrent glioblastoma multiforme 56 biliary strictures produced 56 VIVITROL ® 56 aztreonam lysine 56 R sorafenib tablets 56 balsalazide tablet 56 SinuNase TM 56 Begins Dosing 56 OMAPRO ™ 56 Rhucin ® recombinant 56 rotigotine transdermal patch 56 CNTO 56 Orphan Designation 56 DosePro TM 56 MKC# MT 56 Fortigel 56 Vimpat ® lacosamide 56 HeartWare System 56 intravenous acetaminophen 56 Sanofi aventis EURONEXT SAN 56 XIAFLEX ™ 56 CryoSeal FS System 56 Abstral ® 56 chronic ITP patients 56 Intravenous Human 56 dextromethorphan quinidine 56 Dacogen injection 56 BYETTA ® 56 Somatuline Depot 56 REVLIMID R 56 Zalbin 56 ANDA Filing 56 Orathecin 56 Receives Positive Opinion 56 Sebivo 56 containing granisetron 56 Torisel temsirolimus 56 undergoing coronary angioplasty 56 angioedema attacks 56 IN PATIENTS WITH 56 BRILINTA 56 cinacalcet HCl 56 therapeutically inactive prodrug 56 Advagraf 56 mesylate tablets approved 56 Dupuytren Contracture 56 Receives Marketing Authorization 56 Mycograb 56 USFDA approval 56 Anturol TM 56 CIMZIA TM certolizumab pegol 56 chronic idiopathic thrombocytopenic purpura 56 SEBIVO 56 NASDAQ ISTA 56 Increlex R 56 HPV vaccine Cervarix 56 essential thrombocythemia ET 56 novel histone deacetylase 56 chronic eosinophilic leukemia 56 formerly LymphoStat B 56 Junovan TM 56 painful diabetic neuropathy 56 Reminyl galantamine 56 Zytiga 56 Not Approvable 56 Nexavar tablets 56 Sprycel dasatinib 56 Investigational Treatment 56 Completes Enrollment 56 rHuPH# recombinant human 56 Immune Globulin Human 56 Amrubicin 56 ARCOXIA 56 NYSE Amex PTN 56 Inc. NASDAQ BPAX 56 Phase 2b Clinical Trial 56 Alvesco ® 56 stable angina pectoris 56 Nexavar prescribing 56 docetaxel Injection Concentrate 56 Cimzia ® certolizumab pegol 56 Kepivance 56 neurogenic bladder 56 R lenalidomide 56 Bayer Nexavar 56 Octreolin 55 MAA submission 55 Severe Sepsis 55 ATryn ® GTC recombinant 55 severe gastroparesis 55 ACTIQ ® 55 Receives Complete Response 55 sNDAs 55 Pafuramidine 55 Familial Adenomatous Polyposis FAP 55 #/#mg 55 gluteal injection 55 aripiprazole Abilify 55 Promacta 55 Testosterone MDTS ® 55 Expanded Indication 55 novel emulsion formulation 55 Premarket Approval PMA 55 R bivalirudin 55 bleeding pallor 55 sublingual tablets 55 KIACTA ™ 55 develop GED aPC 55 antibody MT# 55 de novo kidney transplant 55 Vitaros 55 Ixempra 55 telaprevir VX 55 XAGRID 55 pregabalin Lyrica 55 Zevtera TM 55 everolimus tablets 55 BUPHENYL 55 Rectogesic 55 palifermin 55 Synvisc ONE 55 Fludara ® 55 cell lymphoma CTCL 55 Clevudine 55 carbamazepine phenobarbital phenytoin rifampin 55 RELISTOR ® 55 EGRIFTA 55 blood thinner rivaroxaban 55 TEVA.TA 55 chronic immune thrombocytopenic 55 ONCASPAR 55 NOVARTIS 55 Ceplene ® histamine dihydrochloride 55 HFA MDI 55 sBLA 55 MyVax R 55 cetuximab Erbitux R 55 SNT-MC#/idebenone 55 rufinamide 55 CHMP recommendation 55 Adjuvant Treatment 55 sodium benzoate prescription 55 Somatuline R Depot 55 Esbriet pirfenidone 55 ORENCIA ® 55 Risperidone Oral Solution 55 Golimumab 55 StaphVAX R 55 ZADAXIN ® 55 XIAFLEX ® 55 developing Zerenex ferric 55 N acetylgalactosamine 6 55 Dexilant 55 Act PDUFA date 55 Receives Approvable Letter 55 Navelbine R 55 Xolegel 55 Files IND 55 VISICOL R 55 FIRAZYR 55 ABILIFY ® 55 Certolizumab pegol 55 PrevOnco ™ 55 Mepact 55 ELADUR TM 55 submitted supplemental Biologics 55 TOPAMAX R 55 Trelstar R 55 LymphoStat B belimumab 55 transfusional iron overload 55 vinorelbine tartrate 55 efalizumab 55 Presents Positive 55 eltrombopag 55 inhalation powder 55 subcutaneous methylnaltrexone 55 Gamunex C 55 NASDAQ CXSP announced 55 Known hypersensitivity 55 FUSILEV ® 55 silodosin 55 methylnaltrexone bromide subcutaneous injection 55 onset juvenile idiopathic 55 AVASTIN 55 Tarceva TM 55 Supplemental Biologics License Application 55 AVAPRO 55 Submits IND 55 vinflunine 55 Actimmune R 55 non nucleoside inhibitor 55 Modrenal R 55 OMNARIS HFA 55 FIRMAGON R 55 alvimopan 55 ® lenalidomide 55 Methylnaltrexone 55 Silodosin 55 RoACTEMRA 55 Humira adalimumab 55 Kuvan sapropterin dihydrochloride 55 Omigard 55 ZOLINZA 55 miconazole Lauriad R 55 Gleevec Glivec 55 Luveris 55 OSI Tarceva 55 Receive Milestone Payment 55 recurrent herpes labialis 55 Pirespa 55 Gonal f R 55 Xyrem ® 55 prucalopride 55 multiple myeloma MM 55 Multaq dronedarone 55 ATPace TM 55 rheumatoid arthritis osteoarthritis ankylosing 55 Alvesco R 54 URG# targets 54 IL# PE#QQR 54 GW# [003] 54 Fibrillex TM 54 congenital ichthyosis 54 Files Investigational 54 Launches Generic Version 54 eprodisate KIACTA TM 54 KYNAPID 54 Drug Application 54 initiate Phase IIb 54 Tibotec Pharmaceuticals Ltd. 54 ® darbepoetin alfa 54 Proquin XR 54 Initiates Clinical 54 Increlex ® 54 Tigecycline 54 ELIQUIS 54 ARIXTRA R 54 forodesine 54 gastrointestinal stromal tumor GIST 54 OZURDEX ® 54 Biological License Application 54 severe malignant osteopetrosis 54 Ranexa R 54 Novartis VIRT X 54 Bronchiectasis 54 Aztreonam Lysine 54 Alitretinoin 54 TRISENOX ® 54 Noxafil 54 sunitinib Sutent 54 YONDELIS 54 Anidulafungin 54 benign prostatic hypertrophy BPH 54 methylnaltrexone 54 Brentuximab Vedotin SGN 54 Junovan 54 FRDA 54 Eliquis 54 TORISEL TM 54 Velaglucerase Alfa 54 Angiox R 54 Fast Track designation 54 uremic pruritus 54 TREATMENT OF 54 casopitant 54 Polyphenon ® E 54 Nasdaq DVAX 54 AstraZeneca Symbicort 54 Investigational Oral 54 Systemic Sclerosis 54 post herpetic neuralgia PHN 54 Focetria 54 dihydrochloride 54 Phase IIb Trial 54 diabetic peripheral neuropathic pain 54 Grants Orphan Drug 54 VALSTAR 54 Biologic License Application 54 Velcade bortezomib 54 C1 esterase inhibitor 54 Ecallantide 54 psoriasis rheumatoid arthritis 54 SmPC 54 Vidaza azacitidine 54 advanced metastatic renal 54 Atypical Hemolytic Uremic Syndrome 54 Orencia abatacept 54 Firdapse 54 chronic angina 54 Acetavance TM 54 BioSante Pharmaceuticals Announces 54 headache abdominal pain 54 Mimpara R 54 Initiates Clinical Trial 54 PrevOnco 54 Targretin capsules 54 Preotact 54 Certican 54 Accelerated Approval 54 approvable letters 54 Mg Uk 54 Loramyc R 54 Biologics License Application 54 ACOMPLIA R 54 refractory APL 54 metastatic GIST 54 ALN PCS 54 Rebif interferon beta 1a 54 SYCREST 54 Recombinant interferon alpha 54 Aloxi Injection 54 Cancidas 54 Vfend 54 Edurant 54 ADL# novel 54 etanercept Enbrel 54 Medicinal Products EMEA 54 Mutual Recognition Procedure 54 FDA Oncologic Drugs 54 Jevtana 54 REMICADE ® 54 oral ridaforolimus 54 Investigational Device Exemption 54 Nexavar ® 54 Clinical Trial Application 54 Remicade infliximab 54 Initiate Clinical Trial 54 T Pred 54 NEUPOGEN R 54 SIMPONI TM 54 NDA Submission 54 R abatacept 54 Roche Actemra 54 ferumoxytol Injection 54 Zidovudine Tablets 54 paliperidone palmitate 54 SCHWARZ PHARMA 54 NASDAQ AUXL 54 NASDAQ AVNR 54 SJIA 54 Feraheme ® 54 Nasdaq CRXL 54 Clolar ® 54 Evoltra R 54 Aurograb 54 REVLIMID lenalidomide 54 Orapred ODT 54 SUTENT ® 54 Abstral 54 Vertex hepatitis C 54 Dalbavancin 54 Complete Response Letter CRL 54 Aflibercept 54 LymphoStat B TM 54 Mimpara 54 HCl capsules 54 hereditary deficiency 54 Viviant 54 RhuDex ® 54 NASDAQ SHPGY 54 BiovaxID TM 54 Sutent sunitinib 54 IV FENTORA R 54 Pegintron 53 ABILIFY R 53 Rhucin 53 faropenem medoxomil 53 DATES Comments 53 Nebido 53 LSE PFZ 53 Humanitarian Device Exemption 53 Phase III Trial 53 AG NOVN.VX 53 POSIDUR TM ELADUR TM 53 idiopathic thrombocytopenic purpura ITP 53 Investigational Compound 53 oral ghrelin agonist 53 basiliximab 53 granted Ortec 53 Marketing Approval PMA 53 docetaxel Taxotere ® 53 Tykerb lapatinib 53 Approvable letter 53 Sycrest 53 UCB Keppra 53 Exelon rivastigmine 53 Simulect 53 Campath ® 53 FDA Anti Infective 53 evaluating picoplatin 53 fluvoxamine maleate 53 Daliresp 53 REMOXY NDA 53 neutropenia dehydration dyspnea 53 Divalproex Sodium 53 IV Busulfex 53 Retacrit 53 Rhucin ® 53 European Medicines Evaluation 53 AstraZeneca Iressa 53 PRECISE Trial 53 atypical antipsychotic medication 53 constipation OIC 53 EVIZON TM 53 Azmacort R 53 hepatitis B HBV 53 Nabi HB Intravenous 53 Somatuline Autogel 53 diabetic gastroparesis 53 Phase 2a Trial 53 Sepracor insomnia 53 POSIDUR ™ 53 TYZEKA 53 Civacir 53 C1 Inhibitor 53 desvenlafaxine 53 Soliris eculizumab 53 rheumatoid arthritis Crohn disease 53 FDA Dermatologic 53 cUTI 53 selective modulator 53 Yondelis ® 53 Mycamine 53 PROMUS Element Stent System 53 Congenital Emphysema 53 systemic juvenile idiopathic 53 Extended Release Capsules 53 PRAECIS PHARMACEUTICALS INCORPORATED 53 indinavir Crixivan 53 Stage IIIB IV 53 Plicera 53 IV acetaminophen 53 Ramelteon 53 Azilect R 53 Hycamtin 53 modafinil Tablets C 53 Ticagrelor 53 reslizumab 53 Desvenlafaxine 53 generation purine nucleoside 53 exenatide injection 53 Drug Eluting Stent System 53 THALOMID 53 PGL# 53 Teflaro 53 Namenda XR 53 CIP TRAMADOL ER 53 oxaliplatin Eloxatin 53 Cimzia TM 53 Intravenous Hepatitis B 53 AMEVIVE 53 Pulminiq 53 primary dysmenorrhea 53 LUCENTIS r 53 Ambrisentan 53 arsenic trioxide injection 53 BENLYSTA ® 53 Phase IIb clinical trials 53 Onrigin 53 Submits Investigational 53 Daclizumab 53 Patients Treated With 53 Relistor 53 Icatibant 53 thrombotic disorders 53 Initiates Phase 2b 53 k Premarket Notification 53 cladribine tablets 53 Ciclesonide 53 ezogabine 53 Bazedoxifene 53 infusional 5-FU/LV 53 Sodium Injection 53 anidulafungin 53 UCB Cimzia 53 Loramyc ® 53 Treanda bendamustine 53 Tracleer r 53 Entocort 53 R adalimumab 53 Fortical R 53 Saizen ® 53 MGd 53 Camptosar ® 53 complicated intra abdominal 53 Rasilez HCT 53 rilonacept 53 NASDAQ OSIR 53 Raptiva efalizumab 53 Filgrastim 53 Somatuline R Autogel R 53 Vimpat R 53 Faropenem 53 Adjunctive Therapy 53 albinterferon alfa 2b 53 Uvidem 53 Zavesca R 53 Stedesa 53 WILEX 53 aztreonam 53 human antithrombin 53 Panflu TM Sinovac 53 miconazole Lauriad ® 53 Fast Track Designation 53 disease CDAD 53 pediatric exclusivity 53 darbepoetin alfa Aranesp 53 TYGACIL 53 autologous cellular immunotherapy 53 briakinumab 53 Tesamorelin 53 Pruvel 53 Frovatriptan 53 idursulfase 53 presumed ocular histoplasmosis 53 Emezine 52 dual orexin receptor 52 thymosin alpha 1 52 Gonal f 52 TAXUS Element Stent System 52 QNEXA 52 Tramiprosate ALZHEMED TM 52 RAPTIVA 52 LSE SHP NASDAQ SHPGY 52 Hexvix ® 52 Ceflatonin 52 Nabi HB R 52 REVLIMID ® 52 Valtropin 52 PROVENGE ® 52 omega interferon 52 NEUPOGEN 52 PROMACTA 52 PF # [002] 52 novel bactericidal 52 AGGRASTAT R Injection tirofiban 52 Paliperidone ER 52 Arixtra 52 Fx #A 52 PROVIGIL ® 52 CHMP opinion 52 Achieves Primary Endpoint 52 NASDAQ SHPGY TSX SHQ 52 Complete Response Letter 52 TORISEL 52 AMITIZA lubiprostone 52 Azilect ® 52 Frova ® 52 Fresenius Biotech 52 Potiga 52 situ CIS 52 solifenacin succinate 52 bazedoxifene 52 chronic thromboembolic pulmonary 52 treat chronic sinusitis 52 candidates Azedra TM 52 Serdolect 52 Final Appraisal Determination 52 Vandetanib 52 vandetanib 52 hepatitis C HCV 52 Veronate 52 pegylated interferon alpha 52 small molecule thrombopoietin 52 TELINTRA 52 Human Medicinal Products 52 Initiates Dosing 52 oxymorphone ER 52 Mirapexin 52 Silenor ® doxepin 52 Amgen Nplate 52 Hsp# Inhibitor 52 benign prostatic hypertrophy 52 Mycophenolate Mofetil 52 Afinitor everolimus 52 broad spectrum cephalosporin 52 PEG interferon 52 Troxatyl 52 Initiates Phase 52 Telzir 52 Serdolect ® 52 Fablyn 52 FORADIL 52 MERREM 52 Canvaxin 52 Egrifta 52 Panzem R 52 Impax ANDA 52 systemic fungal infections 52 receptor tyrosine kinase inhibitor 52 anthracyclines taxanes 52 tazobactam 52 donepezil hydrochloride 52 EGRIFTA ™ 52 Genasense ® 52 Temodar ® 52 CIMZIA ® 52 NASDAQ BDSI 52 Onbrez Breezhaler 52 Irinotecan Hydrochloride Injection 52 fidaxomicin 52 ORENCIA R 52 Serostim R 52 Campto 52 Psoriasis Drug 52 Herceptin trastuzumab 52 OvaRex ® MAb 52 PD LID 52 Entereg TM 52 IND Investigational New 52 Vicriviroc 52 Marketing Authorisation Holder 52 5 HT3 antagonist 52 Angiox 52 Glycopyrrolate 52 Regeneron Pharma 52 Product Characteristics 52 QNEXA ® 52 Cimzia ® 52 Scientific Advice 52 OrCel R 52 Eloxatin oxaliplatin 52 receiving INTRON 52 Zelmac 52 DepoDur 52 developing ACAPODENE 52 posterior uveitis 52 Eribulin 52 DELATESTRYL R 52 Oral Solution 52 trospium chloride 52 GRALISE 52 Afatinib 52 Gets FDA Clearance 52 Product Monograph 52 Novartis Galvus 52 MEZAVANT 52 severe oral mucositis 52 pancreatic enzyme replacement 52 blood thinner prasugrel 52 tramiprosate ALZHEMED TM 52 Kristalose R 52 beta 1a 52 Metformin GR 52 Fortovase 52 Behcet uveitis 52 XIAPEX ® 52 evaluating tivozanib 52 tyrosine kinase inhibitor TKI 52 Kynapid 52 unresectable HCC 52 aggressive systemic mastocytosis 52 administered concomitantly 52 plc LSE SHP 52 Recombinant Human 52 Bifeprunox 52 Aloxi ® 52 Resolor 52 Decentralized Procedure 52 sitagliptin metformin 52 Levitra vardenafil 52 IBS C 52 Toctino ® alitretinoin 52 MAb therapy 52 ONGLYZA ™ 52 Tracleer ® bosentan 52 Oral BDP 52 www.emagazine.com/earthtalk/thisweek/ 52 MACUGEN 52 Adcirca 52 Shonin approval 52 APPROVAL OF 52 RELISTOR subcutaneous injection 52 generic Lipitor 52 Irinotecan 52 Ganciclovir 52 Thrombin topical Recombinant 52 AMMONUL R sodium phenylacetate 52 cytokine immunomodulator 52 CCR5 mAb 52 CERVARIX R 52 docetaxel Taxotere R 52 Evoltra 52 granulated mesalamine 52 thalidomide Thalomid 52 psoriasis Crohn disease 52 dual endothelin receptor antagonist 52 nucleoside analog 51 Optaflu 51 Zavesca ® 51 JAK2 Inhibitor 51 Arranon 51 Stavzor 51 abatacept Orencia 51 stage IIIb IV 51 gepirone ER 51 topical non steroidal 51 reflux disease GERD 51 Wyeth Torisel 51 Zavesca 51 histamine dihydrochloride 51 oral deforolimus 51 AMMONUL R 51 RhuDex TM 51 Myfortic 51 acute bacterial exacerbations 51 Horizant 51 lipoglycopeptide